Chrysophanic acid
 | |
| Names | |
|---|---|
| IUPAC name
1,8-Dihydroxy-3-methyl-9,10-anthraquinone | |
| Identifiers | |
| 481-74-3 | |
| 3D model (Jmol) | Interactive image |
| ChEBI | CHEBI:3687 |
| ChemSpider | 9793 |
| ECHA InfoCard | 100.006.885 |
| PubChem | 10208 |
| |
| |
| Properties | |
| C15H10O4 | |
| Molar mass | 254.24 g·mol−1 |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| Infobox references | |
Chrysophanic acid, also known as chrysophanol, is a fungal isolate and a natural anthraquinone with anti-cancer activity.[1]
Drug action
Chrysophanol induces the necrosis of cancer cells via a reduction in ATP levels.[2] Chrysophanol attentuates the effects of lead exposure in mice by reducing hippocampal neuronal cytoplasmic edema, enhancing mitochondrial crista fusion, significantly increasing memory and learning abilities, reducing lead content in blood, heart, brain, spleen, kidney and liver, promoting superoxide dismutase and glutathione peroxidase activities and reducing malondialdehyde level in the brain, kidney and liver.[3]
Notes
- ↑ Lee, MS; Cha, EY; Sul, JY; Song, IS; Kim, JY (2011). "Chrysophanic acid blocks proliferation of colon cancer cells by inhibiting EGFR/mTOR pathway". Phytotherapy research : PTR. 25 (6): 833–7. doi:10.1002/ptr.3323. PMID 21089180.
- ↑ Burnstock, G; Di Virgilio, F (Dec 2013). "Purinergic signalling and cancer.". Purinergic Signalling (journal). 9 (4): 491–540. doi:10.1007/s11302-013-9372-5. PMC 3889385
. PMID 23797685. - ↑ In lead-exposed neonatal mice, chrysophanol attenuates injury to hippocampal neurons. Zhang et al. (2014) http://www.medicalnewstoday.com/releases/279724.php
This article is issued from Wikipedia - version of the 11/7/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.